European Archives - Page 24 of 1194 - European Medical Journal

5 minutes with... Graham Clark, CEO, Phastar

Graham Clark, CEO, Phastar, explores the current state of play in clinical research, the future of AI in the field and values-based business.

New Genetic Score May Guide Leukaemia Treatment

A large new study has confirmed the clinical relevance of a pharmacogenomic score that could help tailor leukaemia treatment and address persistent racial disparities in outcomes.

Emerging Treatments for Hidradenitis Suppurativa

As HS remains underdiagnosed and undertreated, findings such as these could help support more informed, patient-specific therapeutic decisions moving forward.

16 Jul 2025

Unseen burden of CIDP

Explore the current disease burden and possible treatment pathways of chronic inflammatory demyelinating polyneuropathy (CIDP) in this interactive infographic.

Study Reveals Women Digest Oats Better Than Milk

A new in vitro study reveals sex-specific differences in the digestion of milk and oat-based drinks, offering important insights for personalized nutrition and food innovation.

Fast Track Immunity - TBE and rabies

Fast-Track Immunity: Rapid immune protection through advanced vaccination strategies for Tick-borne Encephalitis vaccination and Abbreviated rabies PrEP schedules

Shish Patel, Chiesi

Chiesi's Shish Patel on COPD, the climate and improving care

What is the environmental cost of respiratory illness? In this episode, Shish Patel, Medical Director, Chiesi UK joins Isabel to explore this and COPD’s rising burden.

EHA 2025 Interview: Martin Dreyling

EHA offers an incredible wealth of opportunities; it’s actually quite difficult to choose which highlights to include. We are fortunate to…

Survey shows pharma leaders backing AI and RWD

A new survey has found that the use of AI and real-world data (RWD) is on the rise across the biopharma industry, but hurdles remain.

Antiplatelet Therapy Rivals Anticoagulation for Brain Protection After TAVI

DAPT matches OAC in preventing brain emboli after TAVI, with less cerebral damage seen on MRI scans.